81 related articles for article (PubMed ID: 1645956)
1. Pravastatin, a HMG-CoA reductase inhibitor, blocks the cell cycle progression but not Ca2+ influx induced by IGF-I in FRTL-5 cells.
Tada H; Takada K; Amino N; Miyai K
Biochem Biophys Res Commun; 1991 May; 177(1):17-21. PubMed ID: 1645956
[TBL] [Abstract][Full Text] [Related]
2. Genistein, a tyrosine kinase inhibitor, blocks the cell cycle progression but not Ca2+ influx induced by BAY K8644 in FRTL-5 cells.
Takano T; Takada K; Tada H; Nishiyama S; Amino N
Biochem Biophys Res Commun; 1993 Feb; 190(3):801-7. PubMed ID: 7679900
[TBL] [Abstract][Full Text] [Related]
3. Relationship between proliferation and cell cycle-dependent Ca2+ influx induced by a combination of thyrotropin and insulin-like growth factor-I in rat thyroid cells.
Takada K; Amino N; Tada H; Miyai K
J Clin Invest; 1990 Nov; 86(5):1548-55. PubMed ID: 1700796
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic effect of lithium in FRTL-5 cells can be reversed by blocking de novo cholesterol synthesis and subsequent signal transduction.
Tasevski V; Benn D; King M; Luttrell B; Simpson A
Thyroid; 2000 Apr; 10(4):305-11. PubMed ID: 10807058
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells.
Yada T; Nakata M; Shiraishi T; Kakei M
Br J Pharmacol; 1999 Mar; 126(5):1205-13. PubMed ID: 10205010
[TBL] [Abstract][Full Text] [Related]
6. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
7. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
[TBL] [Abstract][Full Text] [Related]
8. Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling.
Saito J; Kohn AD; Roth RA; Noguchi Y; Tatsumo I; Hirai A; Suzuki K; Kohn LD; Saji M; Ringel MD
Thyroid; 2001 Apr; 11(4):339-51. PubMed ID: 11349832
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin potentiation of insulin-like growth factor-I dependent deoxribonucleic acid synthesis in FRTL-5 cells: mediation by an autocrine amplification factor(s).
Takahashi S; Conti M; Van Wyk JJ
Endocrinology; 1990 Feb; 126(2):736-45. PubMed ID: 2404747
[TBL] [Abstract][Full Text] [Related]
10. Effects of pravastatin, a new HMG-CoA reductase inhibitor, on vitamin D synthesis in man.
Dobs AS; Levine MA; Margolis S
Metabolism; 1991 May; 40(5):524-8. PubMed ID: 1902546
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells.
Yamamoto K; Hirai A; Ban T; Saito J; Tahara K; Terano T; Tamura Y; Saito Y; Kitagawa M
Endocrinology; 1996 May; 137(5):2036-42. PubMed ID: 8612545
[TBL] [Abstract][Full Text] [Related]
12. Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells.
Takahashi SI; Nedachi T; Fukushima T; Umesaki K; Ito Y; Hakuno F; Van Wyk JJ; Conti M
Biochim Biophys Acta; 2001 Jul; 1540(1):68-81. PubMed ID: 11476896
[TBL] [Abstract][Full Text] [Related]
13. Creation of an autocrine model of insulin-like growth factor-I action in transfected FRTL-5 cells.
Dai Z; Takahashi SI; Van Wyk JJ; D'Ercole AJ
Endocrinology; 1992 Jun; 130(6):3175-83. PubMed ID: 1375893
[TBL] [Abstract][Full Text] [Related]
14. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
[TBL] [Abstract][Full Text] [Related]
15. Staurosporine can inhibit the G1-S transition induced by a calcium channel agonist by blocking the pathway independent of phorbol ester-sensitive protein kinase C in rat thyroid cells (FRTL-5).
Takano T; Takada K; Tada H; Nishiyama S; Amino N
Endocr Res; 1994 Aug; 20(3):235-45. PubMed ID: 7527777
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor.
Miettinen TA
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S19-21. PubMed ID: 1904356
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 promotes cell cycle progression via upregulation of cyclin D1 expression through the phosphatidylinositol 3-kinase/nuclear factor-kappaB signaling pathway in FRTL thyroid cells.
Ren M; Zhong X; Ma CY; Sun Y; Guan QB; Cui B; Guo J; Wang H; Gao L; Zhao JJ
Acta Pharmacol Sin; 2009 Jan; 30(1):113-9. PubMed ID: 19060913
[TBL] [Abstract][Full Text] [Related]
18. Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: comparison with FRTL-5 cells.
Kimura T; Dumont JE; Fusco A; Golstein J
Eur J Endocrinol; 1999 Jan; 140(1):94-103. PubMed ID: 10037258
[TBL] [Abstract][Full Text] [Related]
19. Adenosine 3',5'-monophosphate mediates both the mitogenic effect of thyrotropin and its ability to amplify the response to insulin-like growth factor I in FRTL5 cells.
Tramontano D; Moses AC; Veneziani BM; Ingbar SH
Endocrinology; 1988 Jan; 122(1):127-32. PubMed ID: 2446854
[TBL] [Abstract][Full Text] [Related]
20. Hep-G2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductase.
Shaw MK; Newton RS; Sliskovic DR; Roth BD; Ferguson E; Krause BR
Biochem Biophys Res Commun; 1990 Jul; 170(2):726-34. PubMed ID: 2166504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
